Acquired Company
BridgeBio Pharma, Inc. completed its acquisition of all of the outstanding shares of Eidos Therapeutics, Inc. on January 26, 2021.
Show more
101 Montgomery St Ste 2550, California, 94104-4158, US
Start AI Chat
Market Cap
0.00
52 Wk Range
$N/A - $N/A
Previous Close
$122.21
Open
$122.21
Volume
N/A
Day Range
$122.21 - $122.21
Enterprise Value
0.00
Cash
0.00
Avg Qtr Burn
N/A
Insider Ownership
0.00%
Institutional Own.
0.00%
Qtr Updated
06/30/24
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
| Drug & Indication | Stage & Event | Catalyst Date |
|---|